Connecticut 2025 Regular Session

Connecticut House Bill HB07049 Latest Draft

Bill / Comm Sub Version Filed 03/18/2025

                             
 
LCO   	1 of 2 
  
General Assembly  Substitute Bill No. 7049  
January Session, 2025 
 
 
 
 
 
AN ACT CONCERNING THE RECOMMENDATIONS OF THE OFFICE 
OF THE CHILD ADVOCATE REGARDING THE INFANT MORTALITY 
REVIEW PROGRAM.  
Be it enacted by the Senate and House of Representatives in General 
Assembly convened: 
 
Section 1. Subsection (f) of section 19a-59j of the general statutes is 1 
repealed and the following is substituted in lieu thereof (Effective October 2 
1, 2025): 3 
(f) All information obtained by the commissioner, or the 4 
commissioner's designee, for the infant mortality review program shall 5 
be confidential pursuant to section 19a-25, except the commissioner may 6 
disclose any information or data obtained for the infant mortality review 7 
program to the Child Advocate, if the commissioner deems such 8 
disclosure necessary for the Child Advocate to perform the duties set 9 
forth in section 46a-13l. Any information or data disclosed to the Child 10 
Advocate shall be confidential in accordance with section 46a-13n, as 11 
amended by this act. 12 
Sec. 2. Subsection (a) of section 46a-13n of the general statutes is 13 
repealed and the following is substituted in lieu thereof (Effective October 14 
1, 2025): 15 
(a) The name, address and other personally identifiable information 16  Substitute Bill No. 7049 
 
 
LCO     	2 of 2 
 
of a person who makes a complaint to the Child Advocate as provided 17 
in section 46a-13l, all information obtained or generated by the office in 18 
the course of an investigation and all confidential records obtained by 19 
the Child Advocate or a designee shall be confidential and shall not be 20 
subject to disclosure under the Freedom of Information Act or 21 
otherwise, except that such information and records, other than 22 
confidential information concerning a pending law enforcement 23 
investigation or a pending prosecution, may be disclosed if the Child 24 
Advocate determines that disclosure is (1) in the general public interest 25 
or (2) necessary to enable the Child Advocate to perform his 26 
responsibilities under subsection (a) of section 46a-13l. If the Child 27 
Advocate determines that disclosure of confidential information is not 28 
in the public interest but is necessary to enable the Child Advocate to 29 
perform responsibilities under subsection (a) of section 46a-13l, or to 30 
identify, prevent or treat the abuse or neglect of a child, the Child 31 
Advocate may disclose such information to the appropriate agency 32 
responsible for the welfare of such child or the legal representative for 33 
such child. The Child Advocate may disclose information or data 34 
regarding fatalities of infants less than one year of age to the 35 
Commissioner of Public Health if the Child Advocate determines such 36 
disclosure is necessary for the purposes of the infant mortality review 37 
program established pursuant to section 19a-59j, as amended by this act. 38 
Any information or data disclosed to the Commissioner of Public Health 39 
shall be confidential in accordance with the provisions of section 19a-25. 40 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 October 1, 2025 19a-59j(f) 
Sec. 2 October 1, 2025 46a-13n(a) 
 
PH Joint Favorable Subst.